Fund profile
Tickers
BIPIX, BIPSX
Fund manager
Total assets
$110.37 mm
Liabilities
$1.61 mm
Net assets
$108.76 mm
Number of holdings
145.00
145 Holdings
Security | $Holding | Balance | % of Fund | Category | Position | Country |
---|---|---|---|---|---|---|
SOCIETE GENERALE | 5.42 mm | 5.42 mm principal | 4.99 | Repurchase agreement | Long | USA |
HSBC SECURITIES USA INC | 5.18 mm | 5.18 mm principal | 4.76 | Repurchase agreement | Long | USA |
CREDIT AGRICOLE CIB NY | 4.82 mm | 4.82 mm principal | 4.43 | Repurchase agreement | Long | USA |
Natwest Markets PLC | 4.82 mm | 4.82 mm principal | 4.43 | Repurchase agreement | Long | USA |
GILD Gilead Sciences, Inc. | 2.53 mm | 33.31 k shares | 2.33 | Common equity | Long | USA |
AMGN Amgen Inc. | 2.41 mm | 7.26 k shares | 2.22 | Common equity | Long | USA |
ROYAL BANK OF CANADA | 2.41 mm | 2.41 mm principal | 2.21 | Repurchase agreement | Long | USA |
SRPT Sarepta Therapeutics, Inc. | 2.40 mm | 16.87 k shares | 2.21 | Common equity | Long | USA |
ABBV AbbVie Inc. | 2.38 mm | 12.85 k shares | 2.19 | Common equity | Long | USA |
EXAS Exact Sciences Corporation | 2.36 mm | 51.75 k shares | 2.17 | Common equity | Long | USA |
UTHR United Therapeutics Corporation | 2.36 mm | 7.52 k shares | 2.17 | Common equity | Long | USA |
REGN Regeneron Pharmaceuticals, Inc. | 2.26 mm | 2.09 k shares | 2.07 | Common equity | Long | USA |
ALNY Alnylam Pharmaceuticals, Inc. | 2.25 mm | 9.48 k shares | 2.07 | Common equity | Long | USA |
VKTX Viking Therapeutics, Inc. | 2.24 mm | 39.23 k shares | 2.06 | Common equity | Long | USA |
VRTX Vertex Pharmaceuticals Incorporated | 2.23 mm | 4.51 k shares | 2.05 | Common equity | Long | USA |
BMRN BioMarin Pharmaceutical Inc. | 2.19 mm | 25.95 k shares | 2.01 | Common equity | Long | USA |
INCY Incyte Corporation | 2.15 mm | 33.07 k shares | 1.98 | Common equity | Long | USA |
NBIX Neurocrine Biosciences, Inc. | 1.99 mm | 14.09 k shares | 1.83 | Common equity | Long | USA |
BIIB Biogen Inc. | 1.99 mm | 9.35 k shares | 1.83 | Common equity | Long | USA |
NTRA Natera, Inc. | 1.97 mm | 19.21 k shares | 1.81 | Common equity | Long | USA |
MRNA Moderna, Inc. | 1.85 mm | 15.48 k shares | 1.70 | Common equity | Long | USA |
CYTK Cytokinetics, Incorporated | 1.81 mm | 30.66 k shares | 1.66 | Common equity | Long | USA |
Invesco Government & Agency Portfolio | 1.42 mm | 1.42 mm shares | 1.30 | Short-term investment vehicle | N/A | USA |
CRSP CRISPR Therapeutics AG | 1.22 mm | 21.34 k shares | 1.12 | Common equity | Long | Switzerland |
MDGL Madrigal Pharmaceuticals, Inc. | 1.21 mm | 4.26 k shares | 1.11 | Common equity | Long | USA |
BPMC Blueprint Medicines Corporation | 1.20 mm | 11.10 k shares | 1.11 | Common equity | Long | USA |
UMB FINANCIAL CORP | 1.18 mm | 1.18 mm principal | 1.08 | Repurchase agreement | Long | USA |
APLS Apellis Pharmaceuticals, Inc. | 1.12 mm | 28.29 k shares | 1.03 | Common equity | Long | USA |
ROIV Roivant Sciences Ltd. | 1.05 mm | 96.99 k shares | 0.97 | Common equity | Long | Bermuda |
KRYS Krystal Biotech, Inc. | 1.02 mm | 4.89 k shares | 0.94 | Common equity | Long | USA |
RVMD Revolution Medicines, Inc. | 990.57 k | 21.70 k shares | 0.91 | Common equity | Long | USA |
IONS Ionis Pharmaceuticals, Inc. | 976.44 k | 19.74 k shares | 0.90 | Common equity | Long | USA |
CERE Cerevel Therapeutics Holdings Inc | 963.49 k | 21.43 k shares | 0.89 | Common equity | Long | USA |
EXEL Exelixis, Inc. | 957.79 k | 40.84 k shares | 0.88 | Common equity | Long | USA |
INSM Insmed Incorporated | 954.48 k | 13.12 k shares | 0.88 | Common equity | Long | USA |
ALKS Alkermes plc | 921.42 k | 33.73 k shares | 0.85 | Common equity | Long | Ireland |
BHVN Biohaven Ltd. | 899.71 k | 22.88 k shares | 0.83 | Common equity | Long | Virgin Islands (British) |
PCVX Vaxcyte, Inc. | 873.31 k | 11.07 k shares | 0.80 | Common equity | Long | USA |
HALO Halozyme Therapeutics, Inc. | 846.14 k | 15.31 k shares | 0.78 | Common equity | Long | USA |
BBIO BridgeBio Pharma, Inc. | 824.04 k | 31.76 k shares | 0.76 | Common equity | Long | USA |
TGTX TG Therapeutics, Inc. | 778.48 k | 39.40 k shares | 0.72 | Common equity | Long | USA |
DYN Dyne Therapeutics, Inc. | 729.34 k | 17.00 k shares | 0.67 | Common equity | Long | USA |
CRNX Crinetics Pharmaceuticals, Inc. | 696.62 k | 13.11 k shares | 0.64 | Common equity | Long | USA |
IOVA Iovance Biotherapeutics, Inc. | 687.58 k | 78.76 k shares | 0.63 | Common equity | Long | USA |
ACAD ACADIA Pharmaceuticals Inc. | 678.41 k | 35.67 k shares | 0.62 | Common equity | Long | USA |
TWST Twist Bioscience Corporation | 672.62 k | 12.05 k shares | 0.62 | Common equity | Long | USA |
RARE Ultragenyx Pharmaceutical Inc. | 664.05 k | 14.75 k shares | 0.61 | Common equity | Long | USA |
SWTX SpringWorks Therapeutics, Inc. | 654.46 k | 18.23 k shares | 0.60 | Common equity | Long | USA |
NTLA Intellia Therapeutics, Inc. | 639.03 k | 24.38 k shares | 0.59 | Common equity | Long | USA |
ACLX Arcellx, Inc. | 620.14 k | 10.03 k shares | 0.57 | Common equity | Long | USA |
BEAM Beam Therapeutics Inc. | 611.35 k | 19.32 k shares | 0.56 | Common equity | Long | USA |
IDYA IDEAYA Biosciences, Inc. | 604.77 k | 14.05 k shares | 0.56 | Common equity | Long | USA |
NUVL Nuvalent, Inc. | 604.67 k | 7.56 k shares | 0.56 | Common equity | Long | USA |
RNA Avidity Biosciences, Inc. | 582.60 k | 12.78 k shares | 0.54 | Common equity | Long | USA |
FOLD Amicus Therapeutics, Inc. | 550.47 k | 53.39 k shares | 0.51 | Common equity | Long | USA |
GERN Geron Corporation | 536.14 k | 113.11 k shares | 0.49 | Common equity | Long | USA |
CLDX Celldex Therapeutics, Inc. | 532.43 k | 13.97 k shares | 0.49 | Common equity | Long | USA |
VERA Vera Therapeutics, Inc. | 520.86 k | 14.24 k shares | 0.48 | Common equity | Long | USA |
MORF Morphic Holding, Inc. | 493.91 k | 8.72 k shares | 0.45 | Common equity | Long | USA |
KYMR Kymera Therapeutics, Inc. | 490.55 k | 10.62 k shares | 0.45 | Common equity | Long | USA |
ARWR Arrowhead Pharmaceuticals, Inc. | 489.32 k | 17.13 k shares | 0.45 | Common equity | Long | USA |
IMVT Immunovant, Inc. | 478.20 k | 16.45 k shares | 0.44 | Common equity | Long | USA |
SNDX Syndax Pharmaceuticals, Inc. | 472.21 k | 20.80 k shares | 0.43 | Common equity | Long | USA |
DNLI Denali Therapeutics Inc. | 431.62 k | 17.71 k shares | 0.40 | Common equity | Long | USA |
APGE Apogee Therapeutics, Inc. | 426.13 k | 8.75 k shares | 0.39 | Common equity | Long | USA |
ARDX Ardelyx, Inc. | 417.05 k | 75.14 k shares | 0.38 | Common equity | Long | USA |
AGIO Agios Pharmaceuticals, Inc. | 416.90 k | 8.99 k shares | 0.38 | Common equity | Long | USA |
RYTM Rhythm Pharmaceuticals, Inc. | 409.01 k | 8.48 k shares | 0.38 | Common equity | Long | USA |
DVAX Dynavax Technologies Corporation | 407.77 k | 36.44 k shares | 0.37 | Common equity | Long | USA |
ADMA ADMA Biologics, Inc. | 401.83 k | 32.72 k shares | 0.37 | Common equity | Long | USA |
PTCT PTC Therapeutics, Inc. | 397.57 k | 11.75 k shares | 0.37 | Common equity | Long | USA |
BCRX BioCryst Pharmaceuticals, Inc. | 396.41 k | 54.45 k shares | 0.36 | Common equity | Long | USA |
NVAX Novavax, Inc. | 392.20 k | 30.62 k shares | 0.36 | Common equity | Long | USA |
VCEL Vericel Corporation | 390.52 k | 7.73 k shares | 0.36 | Common equity | Long | USA |
RXRX Recursion Pharmaceuticals, Inc. | 381.47 k | 46.52 k shares | 0.35 | Common equity | Long | USA |
AKRO Akero Therapeutics, Inc. | 378.18 k | 14.15 k shares | 0.35 | Common equity | Long | USA |
CPRX Catalyst Pharmaceuticals, Inc. | 373.88 k | 21.69 k shares | 0.34 | Common equity | Long | USA |
JANX Janux Therapeutics, Inc. | 366.66 k | 9.03 k shares | 0.34 | Common equity | Long | USA |
NRIX Nurix Therapeutics, Inc. | 351.26 k | 16.05 k shares | 0.32 | Common equity | Long | USA |
KROS Keros Therapeutics, Inc. | 337.53 k | 6.73 k shares | 0.31 | Common equity | Long | USA |
RCKT Rocket Pharmaceuticals, Inc. | 332.87 k | 13.76 k shares | 0.31 | Common equity | Long | USA |
PTGX Protagonist Therapeutics, Inc. | 329.47 k | 8.80 k shares | 0.30 | Common equity | Long | USA |
MIRM Mirum Pharmaceuticals, Inc. | 326.47 k | 8.05 k shares | 0.30 | Common equity | Long | USA |
VCYT Veracyte, Inc. | 308.95 k | 12.87 k shares | 0.28 | Common equity | Long | USA |
IRWD Ironwood Pharmaceuticals, Inc. | 306.92 k | 44.94 k shares | 0.28 | Common equity | Long | USA |
MYGN Myriad Genetics, Inc. | 305.63 k | 10.93 k shares | 0.28 | Common equity | Long | USA |
ARQT Arcutis Biotherapeutics, Inc. | 305.49 k | 30.34 k shares | 0.28 | Common equity | Long | USA |
SLNO Soleno Therapeutics, Inc. | 304.14 k | 6.31 k shares | 0.28 | Common equity | Long | USA |
KURA Kura Oncology, Inc. | 303.12 k | 14.57 k shares | 0.28 | Common equity | Long | USA |
VRDN Viridian Therapeutics, Inc. | 285.61 k | 16.95 k shares | 0.26 | Common equity | Long | USA |
PRAX Praxis Precision Medicines, Inc. | 279.03 k | 4.84 k shares | 0.26 | Common equity | Long | USA |
PRTA Prothena Corporation plc | 264.07 k | 11.34 k shares | 0.24 | Common equity | Long | Ireland |
IBRX ImmunityBio, Inc. | 262.32 k | 50.94 k shares | 0.24 | Common equity | Long | USA |
DAWN Day One Biopharmaceuticals, Inc. | 250.38 k | 17.50 k shares | 0.23 | Common equity | Long | USA |
SANA Sana Biotechnology, Inc. | 242.39 k | 39.80 k shares | 0.22 | Common equity | Long | USA |
CGEM Cullinan Oncology, Inc. | 236.75 k | 12.24 k shares | 0.22 | Common equity | Long | USA |
MNKD MannKind Corporation | 235.95 k | 40.96 k shares | 0.22 | Common equity | Long | USA |
XNCR Xencor, Inc. | 228.03 k | 11.17 k shares | 0.21 | Common equity | Long | USA |
CDMO Avid Bioservices, Inc. | 224.96 k | 21.55 k shares | 0.21 | Common equity | Long | USA |
SYRE Spyre Therapeutics, Inc. | 215.77 k | 7.85 k shares | 0.20 | Common equity | Long | USA |
Arcturus Therapeutics Holdings, Inc. | 213.98 k | 9.12 k shares | 0.20 | Common equity | Long | USA |
SMMT Summit Therapeutics Inc. | 209.48 k | 19.40 k shares | 0.19 | Common equity | Long | USA |
IMNM Immunome, Inc. | 209.07 k | 13.57 k shares | 0.19 | Common equity | Long | USA |
CDNA CareDx, Inc | 209.02 k | 10.46 k shares | 0.19 | Common equity | Long | USA |
TVTX Travere Therapeutics, Inc. | 203.33 k | 21.31 k shares | 0.19 | Common equity | Long | USA |
COGT Cogent Biosciences, Inc. | 202.83 k | 21.51 k shares | 0.19 | Common equity | Long | USA |
ANAB AnaptysBio, Inc. | 202.32 k | 5.81 k shares | 0.19 | Common equity | Long | USA |
CGON CG Oncology, Inc. Common stock | 198.73 k | 5.96 k shares | 0.18 | Common equity | Long | USA |
FDMT 4D Molecular Therapeutics, Inc. | 198.10 k | 11.17 k shares | 0.18 | Common equity | Long | USA |
OLMA Olema Pharmaceuticals, Inc. | 192.72 k | 11.93 k shares | 0.18 | Common equity | Long | USA |
KINIKSA PHARMACEUTICALS INTERNATIONAL PLC
|
188.49 k | 7.09 k shares | 0.17 | Common equity | Long | Bermuda |
RLAY Relay Therapeutics, Inc. | 186.38 k | 22.67 k shares | 0.17 | Common equity | Long | USA |
RCUS Arcus Biosciences, Inc. | 183.79 k | 11.20 k shares | 0.17 | Common equity | Long | USA |
AVXL Anavex Life Sciences Corp. | 178.21 k | 26.23 k shares | 0.16 | Common equity | Long | USA |
VIR Vir Biotechnology, Inc. | 173.25 k | 17.05 k shares | 0.16 | Common equity | Long | USA |
RGNX REGENXBIO Inc. | 171.91 k | 12.06 k shares | 0.16 | Common equity | Long | USA |
ALT Altimmune, Inc. | 164.77 k | 25.91 k shares | 0.15 | Common equity | Long | USA |
CRBP Corbus Pharmaceuticals Holdings, Inc. | 161.40 k | 2.71 k shares | 0.15 | Common equity | Long | USA |
SAGE Sage Therapeutics, Inc. | 157.80 k | 14.41 k shares | 0.15 | Common equity | Long | USA |
FATE Fate Therapeutics, Inc. | 156.29 k | 29.32 k shares | 0.14 | Common equity | Long | USA |
ETNB 89bio, Inc. | 153.71 k | 16.78 k shares | 0.14 | Common equity | Long | USA |
ORIC ORIC Pharmaceuticals, Inc. | 152.17 k | 13.59 k shares | 0.14 | Common equity | Long | USA |
ATXS Astria Therapeutics, Inc. | 149.98 k | 12.84 k shares | 0.14 | Common equity | Long | USA |
CCCC C4 Therapeutics, Inc. | 145.50 k | 21.72 k shares | 0.13 | Common equity | Long | USA |
ALLO Allogene Therapeutics, Inc. | 143.38 k | 48.77 k shares | 0.13 | Common equity | Long | USA |
SRRK Scholar Rock Holding Corporation | 141.18 k | 15.55 k shares | 0.13 | Common equity | Long | USA |
STOK Stoke Therapeutics, Inc. | 139.82 k | 9.34 k shares | 0.13 | Common equity | Long | USA |
EDIT Editas Medicine, Inc. | 135.92 k | 25.12 k shares | 0.12 | Common equity | Long | USA |
OCGN Ocugen, Inc. | 130.94 k | 93.20 k shares | 0.12 | Common equity | Long | USA |
VERV Verve Therapeutics, Inc. | 122.14 k | 17.45 k shares | 0.11 | Common equity | Long | USA |
IRON Disc Medicine, Inc. | 121.02 k | 2.80 k shares | 0.11 | Common equity | Long | USA |
MDXG MiMedx Group, Inc. | 120.34 k | 16.15 k shares | 0.11 | Common equity | Long | USA |
HUMA Humacyte, Inc. | 115.36 k | 12.19 k shares | 0.11 | Common equity | Long | USA |
SPRY ARS Pharmaceuticals, Inc. | 108.43 k | 9.98 k shares | 0.10 | Common equity | Long | USA |
VYGR Voyager Therapeutics, Inc. | 95.89 k | 10.43 k shares | 0.09 | Common equity | Long | USA |
HRTX Heron Therapeutics, Inc. | 89.44 k | 30.11 k shares | 0.08 | Common equity | Long | USA |
CABA Cabaletta Bio, Inc. | 85.99 k | 12.11 k shares | 0.08 | Common equity | Long | USA |
TNGX Tango Therapeutics, Inc. | 83.94 k | 8.52 k shares | 0.08 | Common equity | Long | USA |
CRGX CARGO Therapeutics, Inc. Common Stock | 80.55 k | 4.73 k shares | 0.07 | Common equity | Long | USA |
ZNTL Zentalis Pharmaceuticals, Inc. | 76.21 k | 19.59 k shares | 0.07 | Common equity | Long | USA |
ITOS iTeos Therapeutics, Inc. | 74.00 k | 4.21 k shares | 0.07 | Common equity | Long | USA |
SVRA Savara Inc. | 72.95 k | 15.86 k shares | 0.07 | Common equity | Long | USA |
ALEC Alector, Inc. | 70.59 k | 11.77 k shares | 0.06 | Common equity | Long | USA |
TOTAL RETURN SWAP AGREEMENT BASED ON THE DOW JONES U.S. BIOTECHNOLOGY INDEX
UBS SECURITIES LLC
|
-343.92 k | 5.22 k other units | -0.32 | Equity derivative | N/A | USA |
TOTAL RETURN SWAP AGREEMENT BASED ON THE DOW JONES U.S. BIOTECHNOLOGY INDEX
GOLDMAN SACHS GROUP, INC
|
-363.61 k | 4.85 k other units | -0.33 | Equity derivative | N/A | USA |